- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04691310
The Efficacy of Kinesio Taping on Lymphedema Following Head and Neck Cancer Therapy
July 27, 2021 updated by: Sevgi Atar, Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
The Efficacy of Kinesio Taping on Neck Lymphedema Following Head and Neck Cancer Therapy: Double Blind Randomized Placebo Controlled Study
Purpose off the study is investigating to efficacy of kinesio taping on neck lymphedema after the head and neck cancer therapy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The neck lymphedema is a multidirectional process that depends on lymphatic circulation issues.
The lymphedema can be treated using such as therapies, drugs or surgeries.
There are few techniques for treatment of neck lymphedema and also in our best knowledge the kinesio taping therapy on lymphedema following neck cancer therapy had not been investigated or published.
The study will assess the efficacy of kinesio taping in neck lymphedema with manual therapy after the head and neck cancer treatment.
Study Type
Interventional
Enrollment (Actual)
58
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey, 34384
- Prof Dr Cemil Tascioglu City Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age between 18-70 years
- External neck lymphedema
- Head and neck cancer treatment patients
- patients who have not open wound on neck
- Patients who were accept to consent form
Exclusion Criteria:
- Mental disorders Cognitive limitations Pregnancy Out of age 18-70 years old Patients who were not accept to consent form
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Kinesio taping study
Kinesio tex gold tape was applied to neck localised lymphedema as stretched.
Kinesio tape maintained during consecutive days and also were re applied with manual lymphatic drainage therapy as 5 times first week, and afterthat 2 times for 3 weeks (total 4 weeks)
|
The Kinesio Tex Gold is a kinesio tape that had been certified and patented.
|
|
SHAM_COMPARATOR: Kinesio taping sham
Kinesio tex gold tape was applied to neck localised lymphedema as no-stretched.
Kinesio tape maintained during consecutive days and also were re applied with manual lymphatic drainage therapy as 5 times first week, and afterthat 2 times for 3 weeks (total 4 weeks)
|
The Kinesio Tex Gold is a kinesio tape that had been certified and patented.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The values of diameter of lymphedema of neck with face
Time Frame: Baseline
|
The diameters of upper, middle and lower points of neck were measured with tailor meter by a Physical Medicine and Rehabilitation professionals (measure unit is cm).
|
Baseline
|
|
The values of diameter of lymphedema of neck with face
Time Frame: 2 weeks
|
The diameters of upper, middle and lower points of neck and two points of face were measured with tailor meter by a Physical Medicine and Rehabilitation professionals (measure unit is cm).
|
2 weeks
|
|
The values of diameter of lymphedema of neck with face
Time Frame: 4 weeks
|
The diameters of upper, middle and lower points of neck and two points of face were measured with tailor meter by a Physical Medicine and Rehabilitation professionals (measure unit is cm).
The changes were assessed from baseline neck diameter at end of treatment and after one month.
|
4 weeks
|
|
The values of diameter of lymphedema of neck with face
Time Frame: 8 weeks
|
The diameters of upper, middle and lower points of neck were measured with tailor meter by a Physical Medicine and Rehabilitation professionals (measure unit is cm).
The changes were assessed from baseline neck diameter at end of treatment and after one month.
|
8 weeks
|
|
The outcomes of Quality of Life Questionnaire-Head and Neck 35
Time Frame: baseline
|
It was assessed by Quality of Life Questionnaire-Head and Neck 35 that a self questionnaire in head and neck cancer patients.
The minimum score is 0 and maximum score is 100.
The high scores were worst low scores were good health.
|
baseline
|
|
The outcomes of Quality of Life Questionnaire-Head and Neck 35
Time Frame: 4 weeks
|
It was assessed by Quality of Life Questionnaire-Head and Neck 35 that a self questionnaire in head and neck cancer patients.
The minimum score is 0 and maximum score is 100.
The high scores were worst low scores were good health.
|
4 weeks
|
|
The outcomes of Quality of Life Questionnaire-Head and Neck 35
Time Frame: 8 weeks
|
It was assessed by Quality of Life Questionnaire-Head and Neck 35 that a self questionnaire in head and neck cancer patients.
The minimum score is 0 and maximum score is 100.
The high scores were worst low scores were good health.
|
8 weeks
|
|
The scores of head and neck external lymphedema rating scale
Time Frame: Baseline
|
They were assessed by M. D. Anderson head and neck lymphedema rating scale in head and neck cancer patients.
Composite Score ranges from 0 ( low edema) to 3 (high level edema).
|
Baseline
|
|
The scores of head and neck external lymphedema rating scale
Time Frame: 2 weeks
|
They were assessed by M. D. Anderson head and neck lymphedema rating scale in head and neck cancer patients.
Composite Score ranges from 0 ( low edema) to 3 (high level edema).
|
2 weeks
|
|
The scores of head and neck external lymphedema rating scale
Time Frame: 4 weeks
|
They were assessed by M. D. Anderson head and neck lymphedema rating scale in head and neck cancer patients.
Composite Score ranges from 0 ( low edema) to 3 (high level edema).
|
4 weeks
|
|
The scores of head and neck external lymphedema rating scale
Time Frame: 8 weeks
|
They were assessed by M. D. Anderson head and neck lymphedema rating scale in head and neck cancer patients.
Composite Score ranges from 0 ( low edema) to 3 (high level edema).
|
8 weeks
|
|
The outcomes of Patterson larynx pharynx internal edema scale
Time Frame: Baseline
|
It was assessed with Flexible Endoscopic Evaluation Study.
Flexible Endoscopic Evaluation Study results were scored on Patterson larynx pharynx edema scale.
The scores of scale were no, mild, moderate and severe .
The high grade symptom scores were worst, low scores were good health
|
Baseline
|
|
The outcomes of Patterson larynx pharynx edema scale
Time Frame: 2 weeks
|
It was assessed with Fiberoptic Endoscopic Evaluation Study.
Flexible Endoscopic Evaluation Study results were scored on Patterson larynx pharynx edema scale.
The scores of scale were no, mild, moderate and severe.
The high grade symptom scores were worst, low scores were good health
|
2 weeks
|
|
The outcomes of Patterson larynx pharynx edema scale
Time Frame: 4 weeks
|
It was assessed with Fiberoptic Endoscopic Evaluation Study.
Flexible Endoscopic Evaluation Study results were scored on Patterson larynx pharynx edema scale.
The scores of scale were no, mild, moderate and severe.
The high grade symptom scores were worst, low scores were good health
|
4 weeks
|
|
The outcomes of Patterson larynx pharynx edema scale
Time Frame: 8 weeks
|
It was assessed with Fiberoptic Endoscopic Evaluation Study.
Flexible Endoscopic Evaluation Study results were scored on Patterson larynx pharynx edema scale.
The scores of scale were no, mild, moderate and severe.
The high grade symptom scores were worst, low scores were good health
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean of demographic
Time Frame: Baseline
|
Age, gender, history of smoke, history of morbidities, diagnosis, stage, therapies of cancer, lymphedema stages were noted
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Sevgi Atar, Special.,MD, Prof. Dr. Cemil Taşcıoğlu City Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Kasawara KT, Mapa JMR, Ferreira V, Added MAN, Shiwa SR, Carvas N Jr, Batista PA. Effects of Kinesio Taping on breast cancer-related lymphedema: A meta-analysis in clinical trials. Physiother Theory Pract. 2018 May;34(5):337-345. doi: 10.1080/09593985.2017.1419522. Epub 2018 Jan 8.
- Deng J, Murphy BA, Dietrich MS, Wells N, Wallston KA, Sinard RJ, Cmelak AJ, Gilbert J, Ridner SH. Impact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status, and quality of life. Head Neck. 2013 Jul;35(7):1026-35. doi: 10.1002/hed.23084. Epub 2012 Jul 12.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
December 31, 2020
Primary Completion (ACTUAL)
February 28, 2021
Study Completion (ACTUAL)
February 28, 2021
Study Registration Dates
First Submitted
December 26, 2020
First Submitted That Met QC Criteria
December 29, 2020
First Posted (ACTUAL)
December 31, 2020
Study Record Updates
Last Update Posted (ACTUAL)
August 2, 2021
Last Update Submitted That Met QC Criteria
July 27, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 309, 2020-082
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Head and Neck Cancer
-
Robert FerrisAmgenCompletedHead and Neck Cancer | Cancer of Head and Neck | Head Cancer | Neck Cancer | Neoplasms, Head and Neck | Cancer of the Head and Neck | Cancer of Neck | Upper Aerodigestive Tract Neoplasms | Neck Neoplasms | Cancer of the Head | Cancer of the Neck | UADT Neoplasms | Cancer of Head | Head Neoplasms | Head, Neck Neoplasms | Neoplasms, Head and other conditionsUnited States
-
Assiut UniversityRecruitingHead and Neck Cancer | Head and Neck Neoplasms | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and NeckEgypt
-
Mayo ClinicCompletedCancer Head Neck | Cancer Neck | Cancer, HeadUnited States
-
West China HospitalNot yet recruitingHead and Neck Cancer | Malignant Neoplasm | Advanced Head and Neck Carcinoma | Head &Amp; Neck Cancer
-
National Cancer Institute (NCI)TerminatedRecurrent Head and Neck Cancer | Metastatic Head and Neck CancerUnited States
-
Radboud University Medical CenterUnknown
-
Fondazione IRCCS Policlinico San Matteo di PaviaNestle Health Science; Akern SrlCompletedHead-neck CancerItaly
-
University of California, San FranciscoCompleted
-
Uppsala UniversityRegion Östergötland; Region Skane; Region Västerbotten; Swedish Cancer Society; S... and other collaboratorsNot yet recruitingHead and Neck Cancer | Head and Neck Cancer Squamous Cell CarcinomaSweden
-
Shenzhen SiBiono GeneTech Co.,LtdUnknownAdvanced Head and Neck CancerChina
Clinical Trials on Kinesio Tex Gold
-
Baskent UniversityCompletedIncreasing Performance of Healthy AthleteTurkey
-
Prof. Dr. Cemil Tascıoglu Education and Research...Completed
-
Guven Health GroupHacettepe University; Baskent UniversityCompleted
-
Okan UniversityMedical Park Hospital IstanbulCompletedLow Back Pain | Connective Tissue Defect (Diagnosis)Turkey
-
Universidade Cidade de Sao PauloCompletedNonspecific Chronic Low Back PainBrazil
-
Medipol UniversityRecruitingPostoperative Pain | Trismus | Postoperative Edema | Orthognathic SurgeryTurkey
-
Istituto Ortopedico GaleazziTerminated
-
Norwegian School of Sport SciencesCompletedMuscle Weakness | Shoulder PainNorway
-
Norwegian School of Sport SciencesCompletedMuscle Weakness | Anterior Knee Pain | Knee SymptomsNorway
-
University of Nove de JulhoCompleted